Inventor · disambiguated record
Leonid S. Metelitsa
Also filed as: METELITSA LEONID · METELITSA LEONID S
4 granted patents·11 pending applications·0 citations·filing 2012–2025
59Inventor score
Top patents by PatentIndex Score
15 records- 0175US2024325450A1Nkt-cell subset for in vivo persistence and therapeutic activity and propagation of sameBAYLOR COLLEGE MEDICINE·Filed 2024·Application pending·0 cites
- 0272US2024277764A1Targeting the Tumor Microenvironment Using Manipulated NKT CellsBAYLOR COLLEGE MEDICINE·Filed 2023·Application pending·0 cites
- 0367US11266689B2NKT-cell subset for in vivo persistence and therapeutic activity and propagation of sameBAYLOR COLLEGE MEDICINE·Filed 2019·Granted Mar 8, 2022·0 cites·28 claims
- 0460US11458168B2NKT-cell subset for in vivo persistence and therapeutic activity and propagation of sameBAYLOR COLLEGE MEDICINE·Filed 2018·Granted Oct 4, 2022·0 cites·35 claims
- 0559US12291558B2CD1D-restricted NKT cells as a platform for off-the-shelf cancer immunotherapyBAYLOR COLLEGE MEDICINE·Filed 2018·Granted May 6, 2025·0 cites·20 claims
- 0658US2025257115A1Cd1d-restricted nkt cells as a platform for off-the-shelf cancer immunotherapyBAYLOR COLLEGE MEDICINE·Filed 2025·Application pending·0 cites
- 0757US2022348930A1CAR NKTs Expressing Artificial Micro RNA-Embedded shRNA for Downregulation of MHC Class I & II ExpressionBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 0856US12048716B2NKT-cell subset for in vivo persistence and therapeutic activity and propagation of sameBAYLOR COLLEGE MEDICINE·Filed 2016·Granted Jul 30, 2024·0 cites·31 claims
- 0956US2021106622A1Targeting the tumor microenvironment using manipulated nkt cellsMETELITSA LEONID S·Filed 2020·Application pending·0 cites
- 1056US2021220403A1Targeting the tumor microenvironment using manipulated nkt cellsMETELITSA LEONID S·Filed 2020·Application pending·0 cites
- 1152US2024110154A1Engineered NKT Cells for Expansion and In Vivo Preservation and Methods of Use for the Control of Tumor CellsBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 1248US2014255363A1Targeting the tumor microenvironment using manipulated nkt cellsMETELITSA LEONID S·Filed 2012·Application pending·0 cites
- 1347US2023103554A1TNFa SIGNALING TRIGGERS TUMOR-PROMOTING INFLAMMATION THAT CAN BE TARGETED TO THERAPYBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 1442US2021252056A1Immune effector cells and molecular adaptors with an antigen cytokine complex for effective immunotherapyBAYLOR COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 1532US2017281683A1Glypican-3 specific chimeric antigen receptors for adoptive immunotherapyBAYLOR COLLEGE MEDICINE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Leonid S. Metelitsa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →